| Term 
 
        | Feline Asthma Corticosteroids
 |  | Definition 
 
        | -multi faceted MOA -injectable, oral, inhalation
 -Side effects include suppression of the immune system and of the HPA axis
 |  | 
        |  | 
        
        | Term 
 
        | Feline Asthma Inj Corticosteroids
 |  | Definition 
 
        | -Short term in SEVERE cases -Start with IV Dex
 -Inhaled Albuterol q30min
 -supplement oxygen
 -LAST RESORT for chronic therapy: Methylprednisolone (IM once every 4-8 weeks)
 |  | 
        |  | 
        
        | Term 
 
        | Feline Asthma Oral Corticosteroids
 |  | Definition 
 
        | -use if symptoms occur more than once/wk -Prednisolone (start @ high dose and then taper over 2-3mths)
 -Ideally, switch to an inhaled steroid (Albuterol)
 |  | 
        |  | 
        
        | Term 
 
        | Feline Asthma Inhaled Corticosteroids
 |  | Definition 
 
        | Fluticasone proprionate -reduces eosinophilic airway inflammation
 -min systemic immune effects
 -can also supress HPA axis
 -maintenance dose not well defined
 |  | 
        |  | 
        
        | Term 
 
        | Question: When is parenteral Dexamethasone indicated for feline asthma cases?
 |  | Definition 
 
        | For short term tx of severe cases |  | 
        |  | 
        
        | Term 
 
        | Question: Which of the following drugs is preferred for inhaled therapy of feline asthma?
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Question: In feline asthma, oral corticosteroid therapy is more appropriate
 |  | Definition 
 
        | -When symptoms occur several times/wk |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-adrenergic agonists -stabilize mast cells
 -increase mucociliary clearance
 |  | 
        |  | 
        
        | Term 
 
        | Bronchodilators Terbutamine Sulfate
 |  | Definition 
 
        | -Oral and inj preps -emergency tx of resp distress (when Albuterol is not possible)
 -min cardio stimulation
 -hypokalemia possible but RARE
 |  | 
        |  | 
        
        | Term 
 
        | Bronchodilators Albuterol Sulfate
 |  | Definition 
 
        | -inhalant -side effects rare (caution in patients with pre-existing cardiac issues)
 -use as needed (tolerance may develop)
 -paradox: causes bronchospasms
 |  | 
        |  | 
        
        | Term 
 
        | Bronchodilators Anticholinergic Drugs
 MOA
 |  | Definition 
 
        | Block Ach by competing for muscarinic receptors |  | 
        |  | 
        
        | Term 
 
        | Bronchodilators Anticholinergics
 Atropine
 |  | Definition 
 
        | -Aerosolized or IV -NONSPECIFIC MUSCARINIC RECEPTOR ANTAGONIST
 -side effects: tachycardia, mydriasis, ileus, colic in horses, reduced ciliary beat freq, reduced mucus secretion
 Indications:
 -horses: emergency relief
 -SA: organophosphate toxicity, unresponsive to asthmatics
 |  | 
        |  | 
        
        | Term 
 
        | Bronchodilators Anticholinergics
 Glycopyrrolate
 |  | Definition 
 
        | -less toxic than atropine -quaternary amine
 -more polar
 -does not cross BBB
 |  | 
        |  | 
        
        | Term 
 
        | Bronchodilators Anticholinergics
 Ipratropium Bromide
 |  | Definition 
 
        | -more polar -same properties as Atropine except:
 *no CNS signs
 *No effect on mucociliary apparatus
 *little cardiovascular properties
 -use in horses and possibly cats
 |  | 
        |  | 
        
        | Term 
 
        | Question: How often should B-agonists generally be used in feline asthma?
 |  | Definition 
 
        | -as needed for acute flare-ups |  | 
        |  | 
        
        | Term 
 
        | Other Drugs Affecting Bronchospasm and Inflammation 3 of them
 |  | Definition 
 
        | Zafirlukast (Leukotriene receptor antagonist; block bronchorestrictve cysteinyl leukotrienes) 
 Cyproheptadine (Serotonin and H1 agonist; mediator in Type I hypersensitivity in cats)
 
 Cetirizine (H1 receptor antagonist; histamine increased in BALF of asthma cats)
 |  | 
        |  | 
        
        | Term 
 
        | Inhaled therapy in Horses |  | Definition 
 
        | -reduction in side effects Admin of:
 -glucocorticoids (short lived)
 -B-receptor agonists (fast-acting)
 -Anticholinergics (Ipratropium bromide)
 -Cromolyn (prophylactic)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -HORSES -stabilizes mast cells
 -inhibits PAF synthesis
 -administered by nebulization prophylactically
 |  | 
        |  | 
        
        | Term 
 
        | PHT reducers Sildenafil (Viagara)
 |  | Definition 
 
        | -PHT associated with chronic obstructive pulmonary disease -reduces pulmonary arterial pressure in dogs
 -acts as a phosphodiesterase inhibitor --> vasodilation
 -given TID in dogs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indications: prevent coughing due to tracheal collapse, canine bronchitis or when a painful, nonprod, exhausting cough exists with the potential for exacerbating lung damage 
 Contraindications: when the animal has a PRODUCTIVE cough; may prevent infectious fluids and secretions from exiting the body
 |  | 
        |  | 
        
        | Term 
 
        | Cough Suppressants Centrally Active
 Dextromethorpan
 |  | Definition 
 
        | -codeine derivative; NON-NARCOTIC -elevates the threshold for coughing
 -onset in ~30 min; lasts 4-6 hrs
 |  | 
        |  | 
        
        | Term 
 
        | Cough Suppressants Centrally Active
 Diphenoxylate
 |  | Definition 
 
        | -NARCOTIC -used in combo with Atropine (Lomotil)
 |  | 
        |  | 
        
        | Term 
 
        | Cough Suppressants Centrally Active
 Codeine
 |  | Definition 
 
        | -oral -NARCOTIC, CONTROLLED
 -binds to opioid receptors in the cough center and depresses sensitivity to afferent stimuli
 -side effects: constipation, sedation
 -Onset ~30 min; lasts 4-6 hrs
 |  | 
        |  | 
        
        | Term 
 
        | Cough Suppressants Centrally Active
 Butorphanol
 |  | Definition 
 
        | -parenteral and oral admin -NARCOTIC, CONTROLLED
 -MOA similar to codeine
 -onset: 5 min; lasts 90 min
 |  | 
        |  | 
        
        | Term 
 
        | Expectorants and Mucolytics |  | Definition 
 
        | Goal:increase the fluidity of the secretions and facilitate their removal 
 Systemic physiological fluid therapy: SINGLE MOST IMPORTANT THERAPY- MAINTAIN HYDRATION
 
 Saline expectorants: Iodide Salts
 -MOA: irritates mucous glands of the respiratory tract to produce a productive cough
 -Contraindications: hypotyroid patients, pregnant/lactating
 -Drugs: K+ Iodide salt soln, ethylenediamine dihydroiodide
 
 Acetylcysteine
 -decrease viscosity of mucous secretions
 -require an intact mucociliary apparatus
 -reduces disulfide bonds in mucoproteins
 -increase levels of glutathione (scavengers of free radicals)
 |  | 
        |  | 
        
        | Term 
 
        | Respiratory Stimulants Doxapram
 |  | Definition 
 
        | -stimulate chemoreceptors of carotid artery and aorta 
 Indications:
 -drug-induced medullar depression
 -apnea in neonates
 -detection of laryngeal paralysis
 |  | 
        |  | 
        
        | Term 
 
        | Question: Which of the following cough supressants is a non-narcotic?
 |  | Definition 
 | 
        |  |